GOOD
INDIA
ANDHRA PRADESH
Natco Pharma gets USFDA’s EIR for Visakhapatnam plant

August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
The Hindu BusinessLine पर मूल खबर पढ़ें ↗
August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
The Hindu BusinessLine पर मूल खबर पढ़ें ↗